I suspect $30-$50pps and that this one will be sold prior to FDA approval. They are probably already talking to several of the majors.
Sellers here and now will miss the next couple hundred percent gain, but I'd be the first to say there is no sin in taking profits.
Personally, I've bought some puts and will buy some more as the stock moves up. Got Jan leaps as well as May calls, and happy to see how far this one can go. Sold my Apr calls, and oh man the money left on the table!!!, but they were to pay for the other calls so such is the cost of hedging...
Big pharma is straped for cash?? are you crazy they are loaded look @ DNA/Roache I would say there half dozens companies with the cash and need to fill pipeline BMY, PFE, LLY, JnJ, just to name a few and don't forget Icahn, Kirk, Warren and a few others whales. This could be on a lot of radar screens.JMHO
The Big boys have billions in cash.....what they don't have is new viable pipeline products to backfill for block busters going generic. There will be a bidding war and it won't be at $17. If the projection is peak sales of >1 billion per year + Ex US sales + possible Breast cancer...colon cancer and liver cancer pipeline products equals a >5 billion buyout. Hold for $50 / share or more!!!!